Inhibition of VEGFR2 and EGFR signaling cooperatively suppresses the proliferation of oral squamous cell carcinoma.
Maho OndaAkinobu OtaKunihiro ItoTakayuki OnoSivasundaram KarnanMikako KatoSayuri KondoAkifumi FuruhashiTomio HayashiYoshitaka HosokawaYoshiaki KazaokaPublished in: Cancer medicine (2023)
VEGFR-mediated signaling would be an alternative signaling pathway for the survival of OSCC cells under the disruption of EGFR signaling. These results highlight the clinical application of VEGFR inhibitors in the development of multi-molecular-targeted therapeutics against OSCC.